Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome
Original Article|Updated:2026-08-04
|
Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome
Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome
中国结合医学杂志(英文版)2026年32卷第8期 页码:693-701
Affiliations:
Department of Traditional Chinese Medicine Pharmacy, Hangzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou ( 310007), China
Author bio:
DENG Yuan, E-mail: vivian-dy@sohu.com
Funds:
Zhejiang Province Traditional Chinese Medicine Science and Technology Project(2025ZF011)
JIANG Meng, YANG Xiao-jia, LIU Li-quan, 等. Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome[J]. 中国结合医学杂志(英文版), 2026,32(8):693-701. DOI: 10.1007/s11655-026-3851-3.
JIANG Meng, YANG Xiao-jia, LIU Li-quan, et al. Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome[J]. Chinese Journal of Integrative Medicine, 2026, 32(8): 693-701. DOI: 10.1007/s11655-026-3851-3.
JIANG Meng, YANG Xiao-jia, LIU Li-quan, 等. Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome[J]. 中国结合医学杂志(英文版), 2026,32(8):693-701. DOI: 10.1007/s11655-026-3851-3.DOI:
JIANG Meng, YANG Xiao-jia, LIU Li-quan, et al. Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome[J]. Chinese Journal of Integrative Medicine, 2026, 32(8): 693-701. DOI: 10.1007/s11655-026-3851-3.DOI:
Loganin Alleviates CCl4-Induced Acute Liver Injury by Promoting Mitophagy and Inhibiting NLRP3 Inflammasome
摘要
Abstract
Objective:
2
To explore the protective effect and mechanism of loganin
a iridoid glycoside isolated from
Corni Fructus
on carbon tetrachloride (CCl
4
)-induced acute liver injury (ALI) mice model and L-02 cells.
Methods:
2
ALI mice model was developed by an intraperitioneal injection of 0.3% CCl
4
. Thirty 8-week-old male C57BL/6 mice were randomly divided into 5 groups using a random number table
including control
model
loganin (40 and 80 mg/kg)
and silybin (100 mg/kg) groups (
n
=6). After 6 consecutive days of intragastric administration
serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured using an automatic biochemical analyzer. Hepatic pathological changes were observed by hematoxylin-eosin (HE) staining. Levels of interleukin (IL)-6 and tumor necrosis fact
or-α (TNF-α) in liver tissue were detected by enzyme-linked immunosorbent assay (ELISA). Superoxide dismutase (SOD) activity and malondialdehyde (MDA) contents were measured using biochemical kits. Mitochondrial ultrastructure and autophagosome formation were observed by transmission electron microscopy (TEM). Co-localization of mitophagy markers LC3 and TOMM20 were assessed by immunofluorescence (IF). Protein expressions of NOD-like receptor protein 3 (NLRP)3
LC3Ⅱ/LC3Ⅰ
p62
Beclin-1
Atg-7
Parkin
and PINK1 were determined by Western blot.
In vitro
an injury model was established in L-02 hepatocytes stimulated with CCl
4
. Cell viability was assessed by CCK-8 assay
and related mechanisms were evaluated using the aforementioned methods. Besides
CCl
4
-stimulated L-02 cells were intervened with NLRP3 shRNA or Mdivi-1.
Results:
2
Compared with the model group
pre-treatment with loganin (40 and 80 mg/kg) significantly reduced serum AST and ALT levels (
P
<
0.01)
alleviated pathological injuries such as swelling
necrosis
inflammatory infiltration
and lipid vacuolation in liver tissue. Loganin also markedly decreased the levels of IL-6 and TNF-α
increased SOD activity
and reduced MDA content in liver tissues (
P
<
0.05 or
P
<
0.01). Mechanistically
loganin up-regulated the ratios of LC3Ⅱ/LC3Ⅰ and expressions of Beclin-1
Atg-7
Parkin
and PINK1
while down-regulated p62 and NLRP3 protein expressions (
P
<
0.05).
In vitro
experiments further confirmed that loganin attenuated CCl
4
-induced injury in L-02 cells by enhancing mitophagy and inhibiting NLRP3 inflammasome activation
which was reversed by the mitophagy inhibitor Mdivi-1.
Conclusion:
2
Loganin protected against CCl
4
-induced ALI both
in vivo
and
in vitro
by suppressing the NLRP3 inflammasome and enhancing mitophagy.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.
Effect of Taoren Honghua Jian Granule on NLRP3 Inflammasome Expression in Patients with Stable Coronary Artery Disease: A Multi-Center, Double-blind, Randomized Controlled Trial
Tanreqing Injection Inhibits Activation of NLRP3 Inflammasome in Macrophages Infected with Influenza A Virus by Promoting Mitophagy
Role of Mitophagy in Myocardial Ischemia/Reperfusion Injury and Chinese Medicine Treatment
Tongxinluo Ameliorates Myocardial Ischemia-Reperfusion Injury Mainly via Activating Parkin-Mediated Mitophagy and Downregulating Ubiquitin-Proteasome System*
Antioxidant and Antiapoptotic Polyphenols from Green Tea Extract Ameliorate CCl4-Induced Acute Liver Injury in Mice
相关作者
LIU Ping
WANG Yi-ru
DU Min
FENG Xiao-teng
ZHANG Na
MAO Mei-jiao
DU Le-yi
YANG Ying
相关机构
Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Guangming Traditional Chinese Medicine Hospital of Pudong New Area
Shanggang Community Health Service Center of Pudong New Area
School of Life Sciences, Beijing University of Chinese Medicine
Experimental Research Center, China Academy of Chinese Medical Sciences